Tarsus Pharmaceuticals (TARS) Revenue & Revenue Breakdown
Tarsus Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$17.45M
Latest Revenue (Q)
$48.12M
Main Segment (Y)
Product
Tarsus Pharmaceuticals Revenue by Period
Tarsus Pharmaceuticals Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | -32.42% |
2022-12-31 | - | -54.73% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | - |
Tarsus Pharmaceuticals Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 17.90% |
2024-06-30 | - | 47.80% |
2024-03-31 | - | 111.18% |
2023-12-31 | - | 598.88% |
2023-09-30 | - | -87.75% |
2023-06-30 | - | 511.08% |
2023-03-31 | - | -75.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | -100.00% |
2022-06-30 | - | 2734.32% |
2022-03-31 | - | 59.47% |
2021-12-31 | - | -72.74% |
2021-09-30 | - | -94.37% |
2021-06-30 | - | -34.14% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | - |
Tarsus Pharmaceuticals Revenue Breakdown
Tarsus Pharmaceuticals Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 |
---|---|---|---|
License Fees and Collaboration | - | - | - |
Product | - | - | - |
Collaboration Revenue | - | - | - |
License and Service | - | - | - |
Latest
Quarterly Revenue by Product
Product/Service | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Mar 23 | Dec 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 |
---|---|---|---|---|---|---|---|---|---|---|---|
Product | - | - | - | - | - | - | - | - | - | - | - |
License And Collaboration | - | - | - | - | - | - | - | - | - | - | - |
License and Service | - | - | - | - | - | - | - | - | - | - | - |
Collaboration | - | - | - | - | - | - | - | - | - | - | - |
Latest
Tarsus Pharmaceuticals Revenue Breakdown by Country
Quarterly Revenue by Country
Country | Mar 23 | Dec 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 |
---|---|---|---|---|---|---|---|
License And Collaboration | - | - | - | - | - | - | - |
License and Service | - | - | - | - | - | - | - |
Collaboration | - | - | - | - | - | - | - |
Latest
Tarsus Pharmaceuticals Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
TVTX | Travere Therapeutics | - | - |
TRDA | Entrada Therapeutics | - | - |
ETON | Eton Pharmaceuticals | - | - |
GNFT | Genfit | - | - |
HOWL | Werewolf Therapeutics | - | - |
TARS | Tarsus Pharmaceuticals | - | - |
IKNA | Ikena Oncology | - | - |
STOK | Stoke Therapeutics | - | - |
CNTA | Centessa Pharmaceuticals | - | - |
OPT | Opthea | - | - |
DSGN | Design Therapeutics | - | - |
LIAN | LianBio | - | - |
ALDX | Aldeyra Therapeutics | - | - |
NUVL | Nuvalent | - | - |
PHVS | Pharvaris | - | - |
RLYB | Rallybio | - | - |
CNTB | Connect Biopharma | - | - |
ABOS | Acumen Pharmaceuticals | - | - |
GLUE | Monte Rosa Therapeutics | - | - |
NUVB | Nuvation Bio | - | - |
PEPG | PepGen | - | - |
TYRA | Tyra Biosciences | - | - |
ELDN | Eledon Pharmaceuticals | - | - |